Parabacteroides Bacteria Modulate Reward System for Dysregulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for reward dysregulation disorders, such as obesity, addiction, and mental health issues, are inadequate, necessitating an alternative and efficient treatment approach.
Innovation Solution
A composition comprising one or more bacteria from the genus Parabacteroides and/or their extracts or metabolites, administered orally or rectally, to modulate the reward system components, thereby treating or preventing reward dysregulation disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If neuropharmacological compounds and/or psychotherapy are used to treat reward dysregulation disorders, then treatment is provided, but the therapy is inadequate and efficiency is insufficient
Solution Approach 1:
The patent changes the fundamental parameter of treatment from conventional neuropharmacological compounds to probiotic bacteria from the genus Parabacteroides. This parameter change enables new mechanisms of action including modulation of the gut-brain axis, alteration of neurotransmitter production, and regulation of reward system components, thereby improving both reliability and productivity of treatment outcomes for reward dysregulation disorders
Solution Approach 2:
The patent introduces gut microbiota as an intermediary system between the environment and the brain. The Parabacteroides bacteria act as mediators that communicate with the central nervous system through the gut-brain axis, influencing reward processing and emotional regulation. This intermediary approach provides a novel therapeutic pathway that overcomes the limitations of direct neuropharmacological intervention
2Productivity
If conventional therapies are used for reward dysregulation disorders, then treatment is administered, but alternative and efficient therapy is needed
Solution Approach 1:
The patent applies the universality principle by demonstrating that Parabacteroides bacteria can treat multiple types of reward dysregulation disorders including obesity, addiction, depression, anxiety, and schizophrenia. The same probiotic mechanism works across different disorder types, providing a universal therapeutic approach that is both efficient and highly adaptable to various clinical presentations
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively restores balance to the reward system components, reducing symptoms of reward dysregulation disorders by modulating the liking, wanting, and learning components, thereby improving treatment outcomes for mental and neurological disorders.
Implementation Method 1
A composition comprising one or more bacteria from the genus Parabacteroides and/or extracts and/or metabolites thereof
Data Source
AI summary
A composition including one or more bacteria selected from the genus Parabacteroides and/or an extract thereof and/or metabolites thereof. Also, the use of this composition in methods of preventing and/or treating reward dysregulation disorders, including mental disorders, neurological disorders, and combinations thereof, by administering this composition to an individual in need thereof.